Obesity hypoventilation syndrome

01OverviewDefinition, clinical context and the essential points that orientate the chapter.

Obesity increases the mechanical load on the chest wall, reduces functional residual capacity and can impair respiratory drive and upper-airway stability. During sleep, ventilation falls further; repeated nocturnal carbon dioxide retention can progress to sustained awake hypercapnia. The syndrome is frequently missed because breathlessness is attributed to weight and the raised bicarbonate is dismissed as incidental.

The defining diagnostic task is to prove awake hypoventilation and exclude other causes. A raised bicarbonate suggests chronic renal compensation but may result from diuretics or vomiting. An awake blood gas shows PaCO2, pH and oxygenation. Spirometry, medicine review, thyroid testing and neuromuscular or chest-wall assessment are targeted to the differential. OSAHS is then characterised with respiratory polygraphy, while transcutaneous carbon dioxide identifies sustained nocturnal hypoventilation that oximetry alone cannot resolve.

Treatment is chosen by physiology. CPAP can reverse OHS when repeated severe upper-airway obstruction is the dominant sleep mechanism. Bilevel NIV adds inspiratory support and a backup strategy when ventilation remains inadequate. Both require early adherence and interface support. Weight-management care may include behavioural programmes, medicines or bariatric assessment under current NICE eligibility and commissioning rules, but should never be used to delay immediate treatment of respiratory failure.

Key points

OHS is obesity with awake alveolar hypoventilation after excluding another primary cause; it is not synonymous with obesity plus snoring.
Most people with OHS also have OSAHS, but some have predominantly non-obstructive sleep hypoventilation and need a different positive-pressure strategy.
Clues include morning headache, hypersomnolence, dyspnoea, oedema, hypoxaemia, raised serum bicarbonate and unexplained secondary polycythaemia or pulmonary hypertension.
Measure awake PaCO2 with arterial or arterialised capillary gas when OHS is suspected; venous bicarbonate is a useful screen in lower-probability settings but does not establish the diagnosis.
Exclude COPD, neuromuscular weakness, severe chest-wall restriction, hypothyroidism, sedative or opioid effects and other causes of chronic hypoventilation.
Use respiratory polygraphy with overnight carbon dioxide assessment to determine whether severe OSAHS or sustained hypoventilation predominates.
NICE recommends CPAP first line for OHS with severe OSAHS when acute ventilatory failure is absent.
Use NIV when OSAHS is not severe, CPAP is ineffective or poorly tolerated despite optimisation, or ventilatory failure requires direct pressure support.
Add supplemental oxygen only if hypoxaemia persists despite optimised CPAP or NIV, with monitoring for carbon dioxide deterioration.
Positive-pressure therapy stabilises physiology but does not replace respectful, evidence-based weight management and cardiovascular risk care.

02AetiologyUnderlying causes, associations and risk factors, with why each one matters.

Severe obesity

Excess thoracic and abdominal mass increases respiratory load and is necessary to the syndrome, but obesity alone does not prove awake hypoventilation.

Sleep-disordered breathing

Most affected people also have obstructive sleep apnoea, with repeated nocturnal hypoventilation and upper-airway obstruction stressing ventilatory control.

Blunted ventilatory response

Susceptible individuals fail to increase drive sufficiently in response to carbon dioxide and mechanical loading, partly through leptin resistance and chronic adaptation.

Additional respiratory burden

Sedatives, opioids, hypothyroidism, airway disease and chest-wall or neuromuscular disorders may worsen hypercapnia and warrant assessment as alternative or coexisting causes.

03PathophysiologyThe causal sequence from the underlying abnormality to symptoms and harm.

1
Mechanical restriction
Abdominal and chest-wall mass lowers compliance and functional lung volume, increasing the work and oxygen cost of breathing.
2
Sleep hypoventilation
Ventilation falls during sleep as upper-airway obstruction and reduced drive produce recurrent hypercapnia and hypoxaemia, with effects that increase as the pathological process progresses.
3
Renal bicarbonate retention
Repeated carbon dioxide elevation leads the kidneys to retain bicarbonate, blunting the ventilatory response to subsequent hypercapnia.
4
Awake ventilatory failure
The combined mechanical load and altered control eventually sustain daytime alveolar hypoventilation with chronic carbon dioxide retention.

04Clinical features and red flagsSymptoms, examination findings, patterns of presentation and time-critical warnings.

Chronic compensated hypoventilation

Daytime sleepiness, morning headache, low resting saturation and raised bicarbonate in a person with obesity suggests chronic carbon dioxide retention even if pH remains near normal.

Acute-on-chronic ventilatory failureRed flag

Infection, fluid overload, sedatives or uncontrolled oxygen can precipitate drowsiness, worsening hypercapnia and acidaemia; absence of dramatic wheeze does not make this less urgent.

Severe OSAHS-dominant OHS

Frequent obstructive respiratory events with snoring and cyclical desaturation occur alongside awake hypercapnia, making CPAP a possible first-line stable treatment under NICE guidance.

Non-obstructive sleep hypoventilation

Sustained nocturnal carbon dioxide rise and desaturation without severe obstructive event burden suggests a need for NIV rather than assuming CPAP alone will restore ventilation.

Cardiopulmonary complicationRed flag

Peripheral oedema, loud pulmonary component, raised JVP, polycythaemia or exertional syncope may reflect pulmonary hypertension and right-heart strain requiring prompt specialist evaluation.

05InvestigationsWhat to request, why it matters and how to interpret it.

Investigation order

Read from the initial assessment onwards. Tests may run in parallel in urgent care; first-line, preferred, confirmatory, definitive and gold-standard labels appear only when the chapter explicitly states them.

01
Awake arterial or arterialised capillary blood gasFirst step
Why
Confirm daytime hypercapnia and quantify acute or chronic compensation.
Interpretation and limitations
Raised PaCO2 with elevated bicarbonate supports chronic hypoventilation; falling pH indicates acute decompensation. Document oxygen because excessive supplementation can alter both PaO2 and PaCO2.
02
Serum bicarbonate
Why
Screen for chronic carbon dioxide retention when pre-test probability is lower.
Interpretation and limitations
A low bicarbonate makes OHS less likely in an appropriate lower-risk setting, while a raised value should prompt blood gas. Diuretics, vomiting and renal disorders limit specificity.
03
Home or hospital respiratory polygraphy
Why
Measure obstructive respiratory-event burden and oxygen pattern.
Interpretation and limitations
Establish whether severe OSAHS coexists, because this directs stable first-line CPAP. Respiratory polygraphy alone may not quantify hypoventilation without carbon dioxide monitoring.
04
Overnight transcutaneous carbon dioxide with oximetry
Why
Demonstrate sustained nocturnal hypoventilation and treatment response.
Interpretation and limitations
A progressive or sustained carbon dioxide rise differs from brief cyclical obstructive events. Assess baseline calibration, leak and oxygen use when interpreting the trace.
05
Spirometry, respiratory muscle and chest imaging assessment
Why
Exclude major obstructive, neuromuscular and chest-wall causes.
Interpretation and limitations
Restriction can accompany obesity but profound weakness, obstruction or structural deformity may be a primary alternative or contributor. Do not diagnose OHS solely from BMI and hypercapnia without this clinical review.
06
Thyroid, medicines and cardiometabolic review
Why
Identify reversible contributors and common complications.
Interpretation and limitations
Hypothyroidism, opioids, hypnotics and alcohol can reduce ventilation. Evaluate blood pressure, diabetes, heart failure and thromboembolic risk as parallel conditions, not proof of OHS.

06Differential diagnosisRealistic alternatives and the features that help distinguish them.

Obstructive sleep apnoea alone

Nocturnal obstruction without confirmed awake hypercapnia indicates OSA rather than obesity hypoventilation syndrome, so the complete clinical pattern must be compared before attributing symptoms.

COPD

Persistent airflow obstruction and emphysema may cause hypercapnia independently; spirometry and imaging identify overlap or an alternative explanation.

Neuromuscular or chest-wall disease

Weakness, deformity and reduced respiratory pressures can explain pump failure despite obesity and require mechanism-specific support.

Medicine-induced hypoventilation

Opioids, sedatives and alcohol reduce central drive, with a temporal relationship and improvement after correction supporting their role.

Hypothyroidism

Severe thyroid deficiency can contribute to reduced drive and weight gain, but biochemical correction does not automatically explain all persistent hypercapnia.

07ManagementImmediate care, first-line treatment, alternatives and escalation.

01DiagnoseProve awake hypoventilationFirst stepObesity coexists with low saturation, raised bicarbonate, sleepiness or morning headache.

1Assess symptoms, respiratory rate, oedema, OSAHS features, medicines, alcohol and prior gases, treating acute decompensation before elective work-up.
2Measure awake arterial or arterialised capillary gas and document oxygen exposure; use bicarbonate only as a screening bridge, not the final diagnosis.
3Exclude COPD, neuromuscular or chest-wall disease, hypothyroidism and medicine-related respiratory depression with targeted testing.
4Arrange respiratory polygraphy and overnight carbon dioxide monitoring to define obstructive versus sustained hypoventilation physiology.

02Stable treatmentMatch positive pressure to phenotypeOHS is confirmed outside acute ventilatory failure.

1First lineIf severe OSAHS predominates, offer CPAP first line and provide early mask, humidification, adherence and pressure troubleshooting.
2Offer NIV when severe OSAHS is absent, CPAP is not tolerated despite support, or hypercapnia and symptoms fail to improve adequately.
3Add oxygen only for persistent hypoxaemia after positive-pressure treatment is optimised, checking carbon dioxide response and device connection.
4Refer to NICE-aligned weight-management care and treat cardiovascular, metabolic and mobility needs without making weight loss a condition of ventilation.

03Acute failureVentilate rather than chase saturationOHS presents with drowsiness, hypercapnic acidosis or severe acute respiratory distress.

1Use ABCDE, controlled oxygen and early blood gas, treating infection, fluid overload, thrombosis, sedative effects and other precipitants.
2EscalationStart acute NIV through a trained respiratory-support or critical-care service when indicated, with an explicit escalation and intubation plan.
3Repeat gas and clinical assessment promptly, improving interface, synchrony and ventilatory support rather than increasing oxygen alone.
4Before discharge, arrange home-ventilation assessment because stopping acute NIV may reveal persistent decompensation or chronic support need.

04ReviewTest physiological effectivenessCPAP or NIV has been used consistently enough for response assessment.

1Review sleepiness, morning headache, breathlessness, oedema and quality of life with device hours, leak and residual obstructive events.
2Repeat awake gas or bicarbonate and overnight oxygen-carbon dioxide control according to severity and the service protocol.
3AlternativeIf hypercapnia persists, check adherence, mask leak, pressure effectiveness and alternative disease before switching CPAP to NIV or changing settings.
4Reassess oxygen need after ventilation improves and continue long-term weight and cardiometabolic support.

Key medicines and prescribing safety3 treatments · regimens, roles and cautions

Prevent upper-airway collapse and thereby improve nocturnal and daytime ventilation in the appropriate OHS phenotype.

CPAP for OHS with severe OSAHS

Use the sleep-service-titrated fixed or auto-adjusting pressure throughout sleep as first-line stable treatment when severe obstructive events predominate.

Do not use CPAP as sole treatment of acute respiratory acidosis. Check adherence, leak and residual carbon dioxide; persistent hypercapnia despite competent optimisation requires specialist consideration of NIV.

Augment tidal ventilation when CPAP is unsuitable, ineffective or acute ventilatory support is required.

Bilevel non-invasive ventilation

Use the specialist-selected interface, inspiratory and expiratory pressures and backup rate nightly, with daytime support added only when clinically prescribed.

Monitor aspiration and secretion risk, mask pressure, leak and synchrony. Acute initiation needs trained monitoring and an escalation plan; home settings should not be changed without the responsible ventilation service.

Correct residual hypoxaemia after upper-airway patency and alveolar ventilation have been addressed.

Supplemental oxygen added to PAP

Use the lowest specialist-titrated flow connected as prescribed only when hypoxaemia persists despite optimised CPAP or NIV.

Oxygen alone does not treat hypoventilation and can worsen carbon dioxide retention. Repeat gas or overnight carbon dioxide assessment, maintain fire precautions and avoid patient-led flow escalation.

08ComplicationsImportant consequences, why they occur and why they matter clinically.

Acute-on-chronic hypercapnic failure

Infection, sedatives or uncontrolled oxygen can precipitate severe acidosis, drowsiness and need for urgent ventilatory support.

Pulmonary hypertension

Chronic nocturnal and daytime hypoxaemia promotes pulmonary vasoconstriction and right-heart strain, creating an additional need for recognition and targeted treatment.

Right-heart failure

Sustained pulmonary pressure and fluid retention produce oedema, venous congestion and worsening exercise tolerance, and potentially prolonging treatment and functional recovery.

Cardiometabolic disease

Obesity, sleep-disordered breathing and hypoxaemia cluster with hypertension, diabetes and cardiovascular events, particularly when baseline cardiopulmonary reserve is limited.

Accidents and cognitive impairment

Sleep fragmentation and hypercapnia cause excessive sleepiness, poor concentration and driving or occupational risk, creating an additional need for recognition and targeted treatment.

09Monitoring and follow-upTreatment response, safety checks and longer-term review.

Track awake PaCO2, pH or bicarbonate and resting oxygenation after treatment initiation and any acute deterioration, recording concurrent oxygen use.
Review CPAP or NIV hours, leak, residual obstruction, pressure tolerance and overnight transcutaneous carbon dioxide when needed to demonstrate ventilatory control.
Assess sleepiness, morning headache, dyspnoea, oedema, admissions and quality of life rather than judging success from device use alone.
Monitor mask skin, nasal and oral dryness, aerophagia, aspiration risk and the patient's ability to apply and remove the interface safely.
Follow weight, blood pressure, diabetes, mobility, pulmonary hypertension and right-heart status through coordinated respiratory and obesity care.

10Special situationsVariants, exceptions and circumstances that change the usual approach.

Bicarbonate remembers the night

Renal bicarbonate retention may expose chronic nocturnal carbon dioxide elevation even when the patient appears well, but other metabolic causes must be considered.

OSAHS can drive daytime failure

In severe OSAHS-dominant OHS, preventing repeated obstruction with CPAP may restore daytime ventilation without bilevel support, explaining the NICE first-line choice.

Oxygen can hide deterioration

A higher saturation after increased oxygen may coexist with rising PaCO2 and worsening acidosis. Consciousness and blood gas remain essential in acute OHS.

Weight care is parallel

Meaningful weight reduction can improve OHS, but respiratory support should start from current physiology and must never be withheld as leverage for weight loss.

Oedema is multifactorial

Peripheral oedema can reflect right-heart strain, left-heart disease, immobility or renal disease. It signals complication but does not diagnose the mechanism alone.

11Common pitfallsFrequent interpretation and management errors.

01
Calling obesity plus snoring OHS without demonstrating awake hypercapnia.
02
Using a raised bicarbonate as definitive proof without blood gas or alternative-cause review.
03
Treating acute drowsy hypercapnic failure with oxygen alone instead of controlled oxygen plus ventilation.
04
Giving every patient NIV without checking whether severe OSAHS makes CPAP an appropriate stable first-line option.
05
Adding nocturnal oxygen before CPAP or NIV is optimised and without carbon dioxide monitoring.
06
Blaming symptoms on weight while overlooking opioids, COPD, neuromuscular disease, hypothyroidism or heart failure.